Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma

Oral Oncology

Volumn 48, Issue 1, 2012, Pages 67-72

  Huang, Shiang Fu ^a,b   Cheng, Sou De ^b   Chien, Huei Tzu ^b   Liao, Chun Ta ^a   Chen, I How ^a   Wang, Hung Ming ^a   Chuang, Wen Yu ^a   Wang, Chun Yi ^b   Hsieh, Ling Ling ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Epidermal growth factor receptor (EGFR); Fluorescence in situ hybridization; Gene amplification; Oral cavity squamous cell carcinoma; Overexpression

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; DISEASE FREE SURVIVAL; EGFR GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECEPTOR GENE; SQUAMOUS CELL CARCINOMA; TAIWAN;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; GENE AMPLIFICATION; GENE DOSAGE; GENES, ERBB-1; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS; TAIWAN; TUMOR MARKERS, BIOLOGICAL;

EID: 84855865509     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.06.511     Document Type: Article

References (39)

1. Department of Health. Cancer Registry Annual Report 2006. Taipei, Taiwan: Bureau of Health Promotion, Department of Health, 2009.
2. C.T. Liao, H.M. Wang, S.H. Ng, T.C. Yen, L.Y. Lee, and C. Hsueh Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan Oral Oncol 42 8 2006 800 809 (Pubitemid 44307760)
3. J.G. Paez, P.A. Janne, J.C. Lee, S. Tracy, H. Greulich, and S. Gabriel EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 5676 2004 1497 1500 (Pubitemid 38720929)
4. W. Pao, V. Miller, M. Zakowski, J. Doherty, K. Politi, and I. Sarkaria EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib Proc Natl Acad Sci U S A 101 36 2004 13306 13311 (Pubitemid 39209661)
5. J.B. Vermorken, R. Mesia, F. Rivera, E. Remenar, A. Kawecki, and S. Rottey Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 11 2008 1116 1127
6. F. Rivera, A. Garcia-Castano, N. Vega, M.E. Vega-Villegas, and L. Gutierrez-Sanz Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial Expert Rev Anticancer Ther 9 10 2009 1421 1428
7. S. Murray, M. Bobos, N. Angouridakis, A. Nikolaou, H. Linardou, and Razis.E. Screening J Oncol 2010 2010 709678
8. T. Hama, Y. Yuza, and Y. Saito J Ou, Kondo S, Okabe M et al. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma Oncologist 14 9 2009 900 908
9. J. Loeffler-Ragg, M. Witsch-Baumgartner, A. Tzankov, W. Hilbe, I. Schwentner, and G.M. Sprinzl Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma Eur J Cancer 42 1 2006 109 111 (Pubitemid 41814540)
10. S.F. Huang, W.Y. Chuang, I.H. Chen, C.T. Liao, H.M. Wang, and Hsieh.L.L. EGFR Protein overexpression and mutation in areca quid-associated oral cavity squamous cell carcinoma in Taiwan Head Neck 31 8 2009 1068 1077
11. Hsieh CH, Chang JW, Hsieh JJ, Hsu T, Huang SF, Liao CT et al. Epidermal growth factor receptor mutations in patients with oral cavity cancer in a betel nut chewing-prevalent area. Head Neck 2011. doi:10.1002/hed.21665.
12. K.K. Ang, B.A. Berkey, X. Tu, H.Z. Zhang, R. Katz, and E.H. Hammond Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 24 2002 7350 7356 (Pubitemid 36025259)
13. I.H. Chen, J.T. Chang, C.T. Liao, H.M. Wang, L.L. Hsieh, and A.J. Cheng Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis Br J Cancer 89 4 2003 681 686 (Pubitemid 37076173)
14. K. Laimer, G. Spizzo, G. Gastl, P. Obrist, T. Brunhuber, and D. Fong High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis Oral Oncol 43 2 2007 193 198 (Pubitemid 46176708)
15. S. Muller, L. Su, M. Tighiouart, N. Saba, H. Zhang, and D.M. Shin Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation Cancer 113 1 2008 97 107 (Pubitemid 351976391)
16. K. Katoh, Y. Nakanishi, S. Akimoto, K. Yoshimura, M. Takagi, and M. Sakamoto Correlation between laminin-5 gamma2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue Oncology 62 4 2002 318 326 (Pubitemid 34914101)
17. W.F. Chiang, S.Y. Liu, C.Y. Yen, C.N. Lin, Y.C. Chen, and S.C. Lin Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas Oral Oncol 44 3 2008 270 276
18. S.J. Rogers, C. Box, P. Chambers, Y. Barbachano, C.M. Nutting, and P. Rhys-Evans Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck J Pathol 218 1 2009 122 130
19. M. Agulnik, G. da Cunha Santos, D. Hedley, T. Nicklee, P.P. Dos Reis, and J. Ho Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib J Clin Oncol 25 16 2007 2184 2190 (Pubitemid 46954641)
20. C.H. Chung, K. Ely, L. McGavran, M. Varella-Garcia, J. Parker, and N. Parker Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas J Clin Oncol 24 25 2006 4170 4176 (Pubitemid 46622295)
21. M. Mrhalova, J. Plzak, J. Betka, and R. Kodet Epidermal growth factor receptor-its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas Neoplasma 52 4 2005 338 343 (Pubitemid 41076203)
22. M. Ryott, D. Wangsa, K. Heselmeyer-Haddad, J. Lindholm, G. Elmberger, and G. Auer EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma Eur J Cancer 45 9 2009 1700 1708
23. Associations of Directors of Anatomic and Surgical Pathology (ADASP) Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms. Mod Pathol 2000; 13(9):1038-41.
24. F. Cappuzzo, F.R. Hirsch, E. Rossi, S. Bartolini, G.L. Ceresoli, and L. Bemis Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer J Natl Cancer Inst 97 9 2005 643 655 (Pubitemid 40812628)
25. F.R. Hirsch, M. Varella-Garcia, J. McCoy, H. West, A.C. Xavier, and P. Gumerlock Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study J Clin Oncol 23 28 2005 6838 6845
26. H.W. Lo, W. Xia, Y. Wei, M. Ali-Seyed, S.F. Huang, and M.C. Hung Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer Cancer Res 65 1 2005 338 348 (Pubitemid 40070827)
27. Z. Liang, X. Zeng, J. Gao, S. Wu, P. Wang, and Shi.X. Analysis BMC Cancer 8 2008 363
28. J. Massano, F.S. Regateiro, G. Januario, and A. Ferreira Oral squamous cell carcinoma: review of prognostic and predictive factors Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 1 2006 67 76 (Pubitemid 44016111)
29. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat Rev Cancer 2 7 2002 489 501 (Pubitemid 37328931)
30. R.R. Seethala, W.E. Gooding, P.N. Handler, B. Collins, Q. Zhang, and J.M. Siegfried Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes Clin Cancer Res 14 5 2008 1303 1309 (Pubitemid 351413908)
31. G.M. Howell, and J.R. Grandis Molecular mediators of metastasis in head and neck squamous cell carcinoma Head Neck 27 8 2005 710 717 (Pubitemid 41113773)
32. J. Kusukawa, H. Harada, I. Shima, Y. Sasaguri, T. Kameyama, and M. Morimatsu The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity Eur J Cancer B Oral Oncol 32B 4 1996 217 221
33. G. Sauter, J. Lee, J.M. Bartlett, D.J. Slamon, and M.F. Press Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations J Clin Oncol 27 8 2009 1323 1333
34. A.M. Gown, L.C. Goldstein, T.S. Barry, S.J. Kussick, P.L. Kandalaft, and P.M. Kim High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system Mod Pathol 21 10 2008 1271 1277
35. P. O-charoenrat, P.H. Rhys-Evans, H. Modjtahedi, and S.A. Eccles The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma Oral Oncol 38 7 2002 627 640 (Pubitemid 34880101)
36. G.T. Thomas, M.P. Lewis, and P.M. Speight Matrix metalloproteinases and oral cancer Oral Oncol 35 3 1999 227 233 (Pubitemid 29148354)
37. J.A. Bonner, P.M. Harari, J. Giralt, N. Azarnia, D.M. Shin, and R.B. Cohen Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 6 2006 567 578 (Pubitemid 43209104)
38. A. Italiano, P. Follana, F.X. Caroli, J.L. Badetti, D. Benchimol, and G. Garnier Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy number Ann Surg Oncol 15 2 2008 649 654
39. F. Cappuzzo, G. Finocchiaro, E. Rossi, P.A. Janne, C. Carnaghi, and C. Calandri EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients Ann Oncol 19 4 2008 717 723 (Pubitemid 351461042)